Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes!! We hit down $0.06 !
Oh yea gonna be down another 5% today GO EUNUCHA GO !!!
Now down $0.05 at this rate we could go to zero in 25 days !!! Shorts making money off eunuchs. Yee Haw !!
Excellent Question but you are not allowed to ask such things here. You must learn the mantra AMRN execs are outstanding AMRN execs have done nothing wrong AMRN execs know what they are doing The stock price is really $26 what's being posted is just a mirage etc PLease do not deviate from this. COntrarian opinions will NOT be tolerated ! Yavol !
Now down $0.02 only 64 days at this rate to zero value - SHorts doubling down their profits on eunuchs.
Capt zBeer - yes the science is wonderful but at this point it's no longer relevant . EUNUCHA's ( formerly AMRN) management couldn't sell water in the desert.
Hee hee Eunucha down 8 more cents LOL now it will take 12 years to get back to $26
GO EUNUCHA GO EUNUCHA
Problem is EUNUCHA ( formerly AMRN ) was given quality materials to build the house but had NO IDEA how to do it . Now they have caused so much damage that it may be difficult to build a structure.
Which is why Thero and the BOD need to be sued BEYOND Insurance coverage.
Hes trying to figure out he extricates himself from this mess called Eunucha ( formerly AMRN ) and break even ..... and so far he's stuck
Down $0.05 - so sad - now its going to take 10 years to get back to $26
My issue with the Canadian system and others is its often the US consumer that pays for most of this research and then places like Canada and the rest of the world pick it up for pennies on the dollar.
Does anyone find it very odd that the UNiformed Fire Officers Family Protection PLan in interested in spending significant cash on lawyers fees to join the Dr. Reddys lawsuit when their cost of vascepa might be under $10,000 per year -- LIzzy might do some investigative research ...
If he wants to save money then he should get rid of the top heavy management, all the execs perks, free stock etc etc oh yes but NOT the SHEROES !!!
Up another 3 cents !!! Yee haw only 4 more years of this and it could hit $26
but if we put inflation in It may be 5 !!
SOmeone needs to ask if they are working on any new condos in Switzerland ...
Like I said ... its MAGIC !!!
It works for smoking as well !!! Amazing ! Heart disease Covid smoking prostate cancer Alzheimer's ...its like MAGIC !!!
Lovaas scripts increasing significantly . Maybe prescribers dont understand the difference in types of fish oil . Hey I have an idea lets write some articles to explain this. NA don't worry Eunucha's marketing arm has this all under control
Its up 3 cents !!! yee haw !! If it does this very day for another 4 years it will be back to $26!!
Which is why if Eunucha ( formerly AMRN ) was on the ball they would have run a statin intolerant branch in REDUCE IT
Market beat analysis from 2 weeks ago
A number of brokerages have recently issued reports on AMRN. Northland Securities cut shares of Amarin from an "outperform" rating to a "market perform" rating in a report on Wednesday, May 4th. SVB Leerink lowered shares of Amarin from an "outperform" rating to a "market perform" rating and reduced their price target for the stock from $10.00 to $3.00 in a research report on Thursday, May 5th. JPMorgan Chase & Co. lowered shares of Amarin from a "neutral" rating to an "underweight" rating in a research report on Friday, May 6th. HC Wainwright downgraded shares of Amarin from a "buy" rating to a "neutral" rating and dropped their price target for the company from $10.00 to $3.00 in a research note on Thursday, May 5th. Finally, StockNews.com raised shares of Amarin from a "sell" rating to a "hold" rating in a research note on Wednesday, July 27th. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat, Amarin presently has an average rating of "Hold" and an average target price of $2.50.
IF it works for cognitive performance can we give it to EUNUCHA ( formerly AMRN ) Execs ?
YOu may be right looks like punk is in the chair and clippers have been started ...lol
Or in other words BUSINESS COMPETENCE AND ACUMEN both items sorely missing at EUNUCHA
Blockbuster drug for the world's major killer and they cant make a go of it ...tragically hilarious
EUNUCHA ( formerly AMRN) couldn't sell water in the desert
Eunucha punk pouring rogaine on that hair
Jroon you have hit the nail on the head EXACTLY !! The only event I see moving things would be healthnet case in 2023 otherwise we can just have fun at EUNUCHA'S expense ...lol
MAybe Eunucha finally realizes that calling EPA fish oil is a no starter. Now calling a compound "MD-2119" well that makes Docs think that this is one of a 1000 compounds that were created and researched to get the absolute best one - it was like mixing ammonia alcohol and water then calling it purple cleaner formula 409 - its all about marketing and EUnucha couldn't sell water in the desert .
BUt you can't remove generics and iNsurance companies will simply substitute generic EPA bid
Eunucha punk got rogaine yesterday ....lol
Well FFS I have to say you finally stated when you were buying and at what cost and I congratulate you on your call .
So has BP picked up on the fact that EPA reduces events by 25% due to anticoagulation and is now pushing their anticoagulants ?
I am seeing a very strong push to use eliquis and xarelto etc as a prevention not only in CAD but also PAD and CVA.
MOre pressure on Eunucha who is unable to capitalize on their own research. Pradaxa was the first NOAC no one even uses it now. They were totally replaced by BP's eliquis and Xarelto .
AF was correct, Eunucha trying to play with the big dogs and they are just lifting their legs.
I'm not so certain BBI - A study using EPA injectable in acute infarct or at cath could easily be performed in 6mos to a year.
What is fascinating is the question
IS Vascepa's benefit also from reduction of coagulation and not from reduction of inflammation or inflammatory cascades or is it both or is coagulation somehow linked to inflammatory cascades ?
and they will do the exact same with the once a day formulation they will just say you need to take generic twice a day
Well you are correct Eunuchas leg may not work and it is missing the wheels
Exactly this is an investment site - we are here to make money whether its long or shorting. CONGRATS to anyone who is making money . FOr those of you who think the only purpose of this site is to serve as a cheerleader for a third rate flunky pharmaceutical firm you have missed the point entirely.
I would bet on Eunucha's management buffoonery as being the most sure and consistent variable with this stock .... GO EUNUCHA !!
No I am still on the sidelines . I actually think the EUNUCHA Punk is stuck in a trading range until some event breaks them loose. BUt congrats if you can make money trading in that range.
The only event I see on the horizon that will do that is the Healthnet case everything else is wishful thinking and the grasping at straws of a drowning company, but as the saying goes "Its not over until the fat EUNUCH sings "
Is EUNUCHA Bankrupt yet ?